SW 780 (ABC-TC1190)

The SW 780 line was established in 1974 by A. Leibovitz from a grade I transitional cell carcinoma.
The patient had preoperative chemotherapy (Thiotepa).
The cells have a reported plating efficiency of 41%.

庫存單位 ABC-TC1190 分類 ,

額外資訊

Product No.

Product Name

Species

Category

Size

Shipping Info

Storage

Supplier Company